Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth ; volume:13 ; number:1 ; day:16 ; month:8 ; year:2022 ; pages:1-12 ; date:12.2022
Nature Communications ; 13, Heft 1 (16.8.2022), 1-12, 12.2022
- Urheber
-
Wang, Xiaolei
Vincent, Eunice
Siddiqui, Summer
Turnbull, Katherine
Lu, Hong
Blair, Robert
Wu, Xueling
Watkins, Meagan
Ziani, Widade
Shao, Jiasheng
Doyle-Meyers, Lara A.
Russell-Lodrigue, Kasi E.
Bohm, Rudolf P.
Veazey, Ronald S.
Xu, Huanbin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-32554-z
- URN
-
urn:nbn:de:101:1-2022110322292782398444
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
12.06.2030, 04:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Xiaolei
- Vincent, Eunice
- Siddiqui, Summer
- Turnbull, Katherine
- Lu, Hong
- Blair, Robert
- Wu, Xueling
- Watkins, Meagan
- Ziani, Widade
- Shao, Jiasheng
- Doyle-Meyers, Lara A.
- Russell-Lodrigue, Kasi E.
- Bohm, Rudolf P.
- Veazey, Ronald S.
- Xu, Huanbin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Increased neutrophil apoptosis in chronically SIV-infected macaques
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
No evidence for ongoing replication on ART in SIV-infected macaques
A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques
Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
The role of MHC class I gene products in SIV infection of macaques
Prolonged AIDS-free Survival for SIV-infected Macaques Treated With Anti-FasL
Brain 18F-FDG PET of SIV-infected macaques after treatment interruption or initiation
Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
Increased neutrophil apoptosis in chronically SIV-infected macaques
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
No evidence for ongoing replication on ART in SIV-infected macaques
A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques
Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
The role of MHC class I gene products in SIV infection of macaques
Prolonged AIDS-free Survival for SIV-infected Macaques Treated With Anti-FasL
Brain 18F-FDG PET of SIV-infected macaques after treatment interruption or initiation
Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
Increased neutrophil apoptosis in chronically SIV-infected macaques
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
No evidence for ongoing replication on ART in SIV-infected macaques
A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques
Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
The role of MHC class I gene products in SIV infection of macaques
Prolonged AIDS-free Survival for SIV-infected Macaques Treated With Anti-FasL
Brain 18F-FDG PET of SIV-infected macaques after treatment interruption or initiation
Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells